Impact of Resistance Training Intensity on Blood Pressure
HEART
High Blood Pressure and Effect of Acute Resistance Training: Influence of Different Load Intensities on Postexercise Hypotension and Ambulatory Blood Pressure in Aging Females
1 other identifier
interventional
36
1 country
1
Brief Summary
The goal of the clinical trial is to understand the effect of two resistance training protocols employing different loading intensities (% of 1 repetition maximum; 1-RM), but with standardized effort intensity (2 repetitions in reserve; RIR) on post-exercise and ambulatory blood pressure in aging females. The main questions it aims to answer are:
- to examine the acute effects of low (50% 1-RM) and high (80% 1-RM) load intensity resistance exercise with a standardized high effort intensity on post-exercise hypotension and ambulatory blood pressure responses in aging females;
- deepen the understanding of the mechanisms underlying acute reductions in blood pressure in response to resistance exercise performed at different load intensities. To this end, autonomic activity will be estimated alongside the measurement of central arterial compliance (i.e., carotid artery), and serum biomarkers of endothelial function;
- document the affective valence and enjoyment associated with low (50% 1-RM) and high (80% 1-RM) load intensity resistance exercise when performed at a high perceived effort. Researchers will compare the effect of: 1) a low load (LL-RE) intensity protocol consisting of 3 sets of each exercise at 50% 1-RM, performed until reaching a hard perceived effort intensity (i.e., RIR-2); 2) high load (HL-RE) intensity protocol consisting of 3 sets of each exercise at 80% of 1-RM, performed until reaching a hard perceived effort intensity (i.e., RIR-2); 3) and a control condition (CON) consisting of a standardized non-fatiguing cognitive task. Participants will participate in:
- A preliminary assessment visit;
- Two familiarization visits to validate the exercise prescriptions;
- Three experimental visits (CON, LL-RE, HL-RE).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2025
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 12, 2025
CompletedFirst Posted
Study publicly available on registry
February 25, 2025
CompletedStudy Start
First participant enrolled
July 8, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2028
September 9, 2025
February 1, 2025
2.8 years
February 12, 2025
September 2, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in blood pressure post-exercise
Oscillometric blood pressure monitor
Before the start of the condition (t = 0 minute), at the end of the condition (t = 60 minutes), each 20 min for 1 hour post-condition (t = 80, 100, 120 minutes)
Change in ambulatory blood pressure
Ambulatory blood pressure monitor
During 24 hours after the condition
Secondary Outcomes (10)
Heart rate variability
Before the start of the condition (t = 0 minute), at the end of the condition (t = 60 minutes), each 20 min for 1 hour post-condition (t = 80, 100, 120 minutes), during 24 hours after the condition
Carotid artery diameter as assessed by Cardiovascular Suite v4.6.1
Before the start of the condition (t = 0 minute), at the end of the condition (t = 60 minutes), 1 hour post-condition (t = 120 minutes)
Carotid artery distensibility as assessed by Cardiovascular Suite v4.6.1
Before the start of the condition (t = 0 minute), at the end of the condition (t = 60 minutes), 1 hour post-condition (t = 120 minutes)
Carotid artery blood flow velocity
Before the start of the condition (t = 0 minute), at the end of the condition (t = 60 minutes), 1 hour post-condition (t = 120 minutes)
Serum endothelin-1
Before the start of the condition (t = 0 minute), at the end of the condition (t = 60 minutes), 1 hour post-condition (t = 120 minutes)
- +5 more secondary outcomes
Other Outcomes (6)
Velocity loss in concentric contraction speed
Continuously during the condition (t = 0 minute to t = 60 minutes)
Hematocrit/hemoglobin concentration
At the end of the condition (t = 60 minutes)
Estimated daily energy expenditure
During 24 hours after the condition
- +3 more other outcomes
Study Arms (3)
Condition LL-RE
EXPERIMENTALLow-load resistance exercise
Condition HL-RE
EXPERIMENTALHigh-load resistance exercise
Condition CON
SHAM COMPARATORControl condition
Interventions
LL-RE condition will consist of a 5-minute warm-up (slow-paced walking) and the following exercises: leg press, chest press, leg curl, and seated row. Three sets will be performed for each exercise with a 3-minute rest period between sets/exercises. Each exercise will be executed through a full range of motion, with participants encouraged to follow a 2-sec eccentric phase (guided by a mobile app metronome and supervised by an exercise physiologist) and to perform the concentric phase as fast as possible. Participants will be informed to: stop the set when they perceive to have reached the RIR target. • LL-RE: The low load intensity protocol consists of 3 sets of each exercise at 50% 1-RM, performed until reaching a hard perceived effort intensity (i.e., RIR-2).
Control condition: During the control condition, participants will sit quietly in a room maintained at a temperature of 22-24°C to prevent any influence on blood pressure values, for 60 minutes. During this period, they will perform a standardized non-fatiguing cognitive task: watching Earth, a documentary following the migration paths of four animal families.
HL-RE condition will consist of a 5-minute warm-up (slow-paced walking) and the following exercises: leg press, chest press, leg curl, and seated row. Three sets will be performed for each exercise with a 3-minute rest period between sets/exercises. Each exercise will be executed through a full range of motion, with participants encouraged to follow a 2-sec eccentric phase (guided by a mobile app metronome and supervised by an exercise physiologist) and to perform the concentric phase as fast as possible. Participants will be informed to: stop the set when they perceive to have reached the RIR target. • HL-RE: The high load intensity protocol consists of 3 sets of each exercise at 80% of 1-RM, performed until reaching a hard perceived effort intensity (i.e., RIR-2).
Eligibility Criteria
You may qualify if:
- aged 50 to 70 years;
- absence of menstruation for 12 consecutive months;
- normal-high resting blood pressure (120 ≤ Systolic ≤ 139 mmHg and 80 ≤ Diastolic ≤ 89 mmHg) or stage 1 hypertension (140 ≤ Systolic ≤ 159 mmHg or 90 \< Diastolic ≤ 99 mmHg);
- physically inactive (\< 150 minutes of structured aerobic physical activity per week);
- and not engaging in regular resistance exercise (≥ 2 sessions per week) for more than 3 months during the year.
You may not qualify if:
- orthopedic limitations or other contraindications to resistance exercise;
- scheduled surgery during the study;
- unstable hypertension (≥ 160/100 mmHg);
- diagnosis of type 2 diabetes;
- cardiovascular event in the past 6 months or sequelae preventing exercise;
- and initiation of hormonal replacement therapy (\< 4 months) known to affect blood pressure.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Research Center on Aging
Sherbrooke, Quebec, J1H 2J7, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Eléonor Riesco, Ph.D.
Université de Sherbrooke
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 12, 2025
First Posted
February 25, 2025
Study Start
July 8, 2025
Primary Completion (Estimated)
May 1, 2028
Study Completion (Estimated)
December 1, 2028
Last Updated
September 9, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will not share